2018
DOI: 10.1111/bjd.16934
|View full text |Cite
|
Sign up to set email alerts
|

Atopic dermatitis: the skin barrier and beyond

Abstract: Dysregulation of innate and adaptive immunity plays a key role; however, recent epidemiological, genetic and molecular research has focused interest on skin barrier dysfunction as a common precursor and pathological feature. Current understanding of the aetiology of atopic dermatitis highlights disruption of the epidermal barrier leading to increased permeability of the epidermis, pathological inflammation in the skin, and percutaneous sensitization to allergens. Thus, most novel treatment strategies seek to t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
190
0
20

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 211 publications
(211 citation statements)
references
References 132 publications
(151 reference statements)
1
190
0
20
Order By: Relevance
“…In addition, from what is known from the general population, the pathogenesis of atopic dermatitis is complicated by contributions from other cytokines . While T H 2 cytokines are associated with the acute phase of allergic inflammation in the skin and contribute to barrier dysfunction, dysregulation of other cytokines including T H 1 cytokines paradoxically contributes to chronic allergic inflammation in the skin.…”
Section: Allergic Diseasementioning
confidence: 99%
“…In addition, from what is known from the general population, the pathogenesis of atopic dermatitis is complicated by contributions from other cytokines . While T H 2 cytokines are associated with the acute phase of allergic inflammation in the skin and contribute to barrier dysfunction, dysregulation of other cytokines including T H 1 cytokines paradoxically contributes to chronic allergic inflammation in the skin.…”
Section: Allergic Diseasementioning
confidence: 99%
“…Patients with AD generally exhibit increased levels of Th2 type cytokines—IL‐4, IL‐5 and IL‐13—during the acute phase of AD and increased levels of Th1 type cytokine IFN‐γ during the chronic phase . Current understanding of the aetiology of AD is that disruption of the epidermal barrier leads to increased permeability of the epidermis, pathological skin inflammation and percutaneous sensitization to allergens . One of the therapeutic approaches aims to maintain or improve epidermal barrier function to ameliorate AD.…”
Section: Introductionmentioning
confidence: 99%
“…AD is a chronic and recurrent cutaneous inflammatory disease that begins in the early stage of life. The pathogenesis of AD is usually linked to skin barrier alteration and immune dysregulation . Indeed, changes in the stratum corneum (SC) composition, which is the outermost layer of the skin, can facilitate the penetration of allergens that can then be associated with the development of AD .…”
Section: Pollution and Skin Pathologiesmentioning
confidence: 99%
“…The pathogenesis of AD is usually linked to skin barrier alteration and immune dysregulation . Indeed, changes in the stratum corneum (SC) composition, which is the outermost layer of the skin, can facilitate the penetration of allergens that can then be associated with the development of AD . As opposed to the outside‐in model of AD pathogenesis, the inside‐out theory suggests that Th2 cytokines are able to modulate the expression of proteins present in the SC, thereby disrupting the skin barrier …”
Section: Pollution and Skin Pathologiesmentioning
confidence: 99%
See 1 more Smart Citation